Compare Allbirds Inc (BIRD) vs Canopy Growth Corp (CGC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Allbirds Inc vs Canopy Growth Corp — how do they compare? Allbirds Inc trades at $2.6 (market cap $30.00M), while Canopy Growth Corp trades at $1.03 (market cap $421.10M). The key difference: Canopy Growth Corp is far larger — about 14× Allbirds Inc's market cap, and Canopy Growth Corp is trading nearer its 52-week high, Allbirds Inc nearer its low. Which is the better fit depends on your goals.
| BIRD | CGC | |
|---|---|---|
Market Cap | $30.00M | $421.10M |
Sector | Consumer Cyclical | Health |
52-Week High | $16.99 | $1.92 |
52-Week Low | $2.21 | $0.86 |
Enterprise Value | $48.86M | $378.55M |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
BIRD stock trades at $2.61, up 1.16% with a bullish technical signal despite mixed moving averages. The company has pivoted from footwear to AI infrastructure, rebranding as Smartbird in June 2026. Revenue declined from $298M in 2022 to $152M in 2025, with persistent negative net margins (-53.36%) and cash burn. Analyst consensus shows 21% buy ratings amid high hold percentage.
The outlook hinges on successful AI strategy execution, but significant risks include sustained losses, declining revenue, and cash flow challenges. Current valuation at P/S 0.15 appears low, yet profitability remains distant. Investors face binary outcome: AI pivot success could drive upside, while failure risks further declines.
Canopy Growth (CGC) trades at $1.02, up 7.13% with a bullish technical signal. The company reported Q1 fiscal 2027 revenue growth of 13% to C$81.2 million and narrowed its EBITDA loss. While revenue trends show stabilization after declining from $520M in 2022 to $269M in 2025, the company continues to post significant net losses with a -222.36% margin. The balance sheet shows improvement with debt-to-asset ratio declining from 53.61% in 2023 to 33.13% in 2025.
CGC presents a high-risk opportunity with potential catalysts from cannabis rescheduling and European expansion. The stock trades below book value (P/B 0.86) but faces substantial execution risks amid persistent losses. Analyst sentiment is mixed with 33% buy ratings, reflecting optimism about restructuring progress versus concerns about profitability timeline.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Allbirds Inc
Allbirds Inc is a global lifestyle brand that innovates with naturally derived materials to make footwear and apparel products. Its primary source of revenue is from sales of shoes and apparel products in its directly owned digital and physical retail channels.
Read more on BIRD →About Canopy Growth Corp
Canopy Growth, headquartered in Smiths Falls, Canada, cultivates and sells medicinal and recreational cannabis, and hemp, through a portfolio of brands that include Tweed, Spectrum Therapeutics, and CraftGrow. Although it primarily operates in Canada, Canopy has distribution and production licenses in more than a dozen countries to drive expansion in global medical cannabis and also holds an option to acquire Acreage Holdings upon U.S. federal cannabis legalization.
Read more on CGC →
